Compare TKO Group Holdings Inc (TKO) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TKO Group Holdings Inc vs Zoetis Inc — how do they compare? TKO Group Holdings Inc trades at $179 (market cap $13.28B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2.3× TKO Group Holdings Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold TKO Group Holdings Inc for 30 Days and Zoetis Inc for 70 Days on average.
| TKO | ZTS | |
|---|---|---|
Market Cap | $13.28B | $30.20B |
Volume | 857,653 | 6,175,327 |
Sector | Media | Health |
52-Week High | $224.96 | $147.53 |
52-Week Low | $175.58 | $69.09 |
Typical Hold Time | 30 Days | 70 Days |
Enterprise Value | $17.64B | $37.76B |
Dividend Yield | 1.74% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TKO trades at $179.38, up 0.41% on the day, but technical indicators signal a bearish trend with the stock near a 52-week low of $174.58 (Defense World, 2026-10-02). The company reported mixed Q2 2026 earnings, missing EPS estimates but raising full-year guidance. Revenue growth remains solid, with 2026 projections at $5.3B, though profitability margins are thin at 4.33% net income margin. A quarterly dividend of $0.79 was declared for payment in September 2026.
Wall Street maintains a bullish stance with 89% buy ratings and a $227 consensus price target, implying significant upside. Key risks include execution on media rights deals, competitive pressures in sports entertainment, and reliance on live events. The stock's high P/E of 63.73 suggests growth expectations must be met to justify valuation.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
